Literature DB >> 19358992

Expression of neuronal nitric oxide synthase splice variants in atherosclerotic plaques of apoE knockout mice.

Johannes Schödel1, P Padmapriya, Alexander Marx, Paul L Huang, Georg Ertl, Peter J Kuhlencordt.   

Abstract

OBJECTIVE: We previously reported that deletion of brain type neuronal nitric oxide synthase-alpha (nNOS-alpha) accelerates atherosclerosis in apolipoproteinE (apoE) knockout (ko) mice. The regulation of nNOS expression is complex, involving the generation of mRNA splice variants. The current study investigates occurrence and distribution of nNOS variants in atherosclerotic lesions of apoE ko and apoE/nNOS-alpha double ko (dko) animals.
METHODS: Mice were fed a high fat diet for 20 weeks. Immunohistochemistry and western blot analysis were performed using antibodies detecting the carboxy terminal-, or amino terminal-residue of the nNOS protein. Confocal microscopy and in situ hybridization were used to identify the compartment of cellular expression.
RESULTS: In situ hybridization revealed the presence of nNOS-alpha and -gamma mRNA variants in apoE ko plaques, while only nNOS-gamma was detectable in apoE/nNOS dko plaques. Consistent with mRNA expression nNOS-alpha protein can be detected in the neointima of apoE ko, but not apoE/nNOS dko animals. In contrast, the carboxy terminal antibody stained the neointima and media in apoE ko vessels and showed residual nNOS immunoreactivity in apoE/nNOS dko lesions. Confocal microscopy showed predominant nNOS expression in vascular smooth muscle cells, while colocalization with macrophages was less pronounced.
CONCLUSIONS: Our study shows that nNOS-alpha and -gamma splice variants are expressed in atherosclerotic plaques of apoE ko mice. nNOS variants colocalized with markers for vascular smooth muscle cells and macrophages but not for endothelial cells. Since nNOS-alpha is atheroprotective, other nNOS splice variants which differ in enzyme kinetic and subcellular localization may also influence plaque formation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19358992      PMCID: PMC2757486          DOI: 10.1016/j.atherosclerosis.2009.02.033

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  43 in total

1.  Potential functional significance of brain-type and muscle-type nitric oxide synthase I expressed in adventitia and media of rat aorta.

Authors:  P M Schwarz; H Kleinert; U Förstermann
Journal:  Arterioscler Thromb Vasc Biol       Date:  1999-11       Impact factor: 8.311

2.  Atheroprotective effects of neuronal nitric oxide synthase in apolipoprotein e knockout mice.

Authors:  Peter J Kuhlencordt; Stefanie Hötten; Johannes Schödel; Sebastian Rützel; Kai Hu; Julian Widder; Alexander Marx; Paul L Huang; Georg Ertl
Journal:  Arterioscler Thromb Vasc Biol       Date:  2006-04-20       Impact factor: 8.311

3.  Site-specific gene expression of nNOS variants in distinct functional regions of rat gastrointestinal tract.

Authors:  Dieter Saur; Winfried L Neuhuber; Bernd Gengenbach; Andrea Huber; Volker Schusdziarra; Hans-Dieter Allescher
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2002-02       Impact factor: 4.052

4.  Cloning, expression, and characterization of a nitric oxide synthase protein from Deinococcus radiodurans.

Authors:  Subrata Adak; Alexandrine M Bilwes; Koustubh Panda; David Hosfield; Kulwant S Aulak; John F McDonald; John A Tainer; Elizabeth D Getzoff; Brian R Crane; Dennis J Stuehr
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-26       Impact factor: 11.205

5.  Vascular smooth muscle and nitric oxide synthase.

Authors:  Igor B Buchwalow; Thomas Podzuweit; Werner Bocker; Vera E Samoilova; Sylvia Thomas; Maren Wellner; Hideo A Baba; Horst Robenek; Jürgen Schnekenburger; Markus M Lerch
Journal:  FASEB J       Date:  2002-04       Impact factor: 5.191

6.  Accelerated atherosclerosis, aortic aneurysm formation, and ischemic heart disease in apolipoprotein E/endothelial nitric oxide synthase double-knockout mice.

Authors:  P J Kuhlencordt; R Gyurko; F Han; M Scherrer-Crosbie; T H Aretz; R Hajjar; M H Picard; P L Huang
Journal:  Circulation       Date:  2001-07-24       Impact factor: 29.690

7.  Neuronal NOS-dependent dilation to flow in coronary arteries of male eNOS-KO mice.

Authors:  An Huang; Dong Sun; Edward G Shesely; Ellen M Levee; Akos Koller; Gabor Kaley
Journal:  Am J Physiol Heart Circ Physiol       Date:  2002-02       Impact factor: 4.733

8.  Functional expression of NOS 1 in vascular smooth muscle.

Authors:  C M Brophy; L Knoepp; J Xin; J S Pollock
Journal:  Am J Physiol Heart Circ Physiol       Date:  2000-03       Impact factor: 4.733

9.  Genetic deficiency of inducible nitric oxide synthase reduces atherosclerosis and lowers plasma lipid peroxides in apolipoprotein E-knockout mice.

Authors:  P J Kuhlencordt; J Chen; F Han; J Astern; P L Huang
Journal:  Circulation       Date:  2001-06-26       Impact factor: 29.690

10.  Increased expression of neuronal nitric oxide synthase spliced variants in reactive astrocytes of amyotrophic lateral sclerosis human spinal cord.

Authors:  M V Catania; E Aronica; B Yankaya; D Troost
Journal:  J Neurosci       Date:  2001-06-01       Impact factor: 6.167

View more
  8 in total

1.  Stimulation of unprimed macrophages with immune complexes triggers a low output of nitric oxide by calcium-dependent neuronal nitric-oxide synthase.

Authors:  Zhi Huang; Fukun W Hoffmann; Jeffrey D Fay; Ann C Hashimoto; Moti L Chapagain; Pakieli H Kaufusi; Peter R Hoffmann
Journal:  J Biol Chem       Date:  2011-12-28       Impact factor: 5.157

Review 2.  Vascular aging: chronic oxidative stress and impairment of redox signaling-consequences for vascular homeostasis and disease.

Authors:  Markus M Bachschmid; Stefan Schildknecht; Reiko Matsui; Rebecca Zee; Dagmar Haeussler; Richard A Cohen; David Pimental; Bernd van der Loo
Journal:  Ann Med       Date:  2012-03-01       Impact factor: 4.709

3.  Decreased production of neuronal NOS-derived hydrogen peroxide contributes to endothelial dysfunction in atherosclerosis.

Authors:  L S A Capettini; S F Cortes; J F Silva; J I Alvarez-Leite; V S Lemos
Journal:  Br J Pharmacol       Date:  2011-11       Impact factor: 8.739

Review 4.  RNA splicing in regulation of nitric oxide receptor soluble guanylyl cyclase.

Authors:  Iraida G Sharina; Gilbert J Cote; Emil Martin; Marie-Francoise Doursout; Ferid Murad
Journal:  Nitric Oxide       Date:  2011-08-16       Impact factor: 4.427

Review 5.  Role of neuronal nitric oxide synthase on cardiovascular functions in physiological and pathophysiological states.

Authors:  Ahmmed Ally; Isabella Powell; Minori M Ally; Kevin Chaitoff; Surya M Nauli
Journal:  Nitric Oxide       Date:  2020-06-23       Impact factor: 4.427

6.  NOS1-derived nitric oxide promotes NF-κB transcriptional activity through inhibition of suppressor of cytokine signaling-1.

Authors:  Mirza Saqib Baig; Sofia V Zaichick; Mao Mao; Andre L de Abreu; Farnaz R Bakhshi; Peter C Hart; Uzma Saqib; Jing Deng; Saurabh Chatterjee; Michelle L Block; Stephen M Vogel; Asrar B Malik; Marcia E L Consolaro; John W Christman; Richard D Minshall; Benjamin N Gantner; Marcelo G Bonini
Journal:  J Exp Med       Date:  2015-08-31       Impact factor: 14.307

7.  Association of nNOS gene polymorphism with ischemic stroke in Han Chinese of North China.

Authors:  Yingjie Dai; Zhiyi He; Rubo Sui; Zhilin Jiang; Shanshan Ma
Journal:  ScientificWorldJournal       Date:  2013-09-03

Review 8.  New insights into oxidative stress and inflammation during diabetes mellitus-accelerated atherosclerosis.

Authors:  Ting Yuan; Ting Yang; Huan Chen; Danli Fu; Yangyang Hu; Jing Wang; Qing Yuan; Hong Yu; Wenfeng Xu; Xiang Xie
Journal:  Redox Biol       Date:  2018-10-19       Impact factor: 11.799

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.